This week, 8 Pharmaceuticals stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
This week, Shire PLC Sponsored ADR (SHPG) drops from a C to a D rating. Shire PLC Sponsored ADR a biopharmaceutical company, researches, develops, manufactures, sells, and distributes pharmaceutical products. The company also gets F’s in earnings momentum. For more information, get Portfolio Grader’s complete analysis of SHPG stock.
ANI Pharmaceuticals Inc (ANIP) earns a D this week, moving down from last week’s grade of C. ANI Pharmaceuticals Inc develops, manufactures, and markets prescription and over-the-counter pharmaceuticals. The company also gets F’s in earnings momentum. For more information, get Portfolio Grader’s complete analysis of ANIP stock.
Lannett Company, Inc.’s (LCI) rating weakens this week, dropping to a D versus last week’s C. Lannett Company, Inc. manufactures and distributes pharmaceutical products under its own trade name and under generic names. For more information, get Portfolio Grader’s complete analysis of LCI stock.
Paratek Pharmaceuticals Inc (PRTK) is having a tough week. The company’s rating falls from a C to a D. The company also gets F’s in earnings revisions, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of PRTK stock.
Foamix Pharmaceuticals Ltd. (FOMX) experiences a ratings drop this week, going from last week’s C to a D. The company also gets F’s in sales growth, earnings surprise, and return on equity. For more information, get Portfolio Grader’s complete analysis of FOMX stock.
BioDelivery Sciences International, Inc. (BDSI) declines this week from a D to a F. BioDelivery Sciences International, Inc. is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology. The company also gets F’s in sales growth, earnings revisions, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of BDSI stock.
Parnell Pharmaceuticals Holdings Ltd. (PARN) gets weaker ratings this week as last week’s C drops to a D. The company also gets F’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of PARN stock.
Slipping from a C to a D rating, Pain Therapeutics, Inc. (PTIE) takes a hit this week. Pain Therapeutics, Inc. develops safer or more efficacious drugs for use in pain management, particularly in the area of opioid painkillers. The company also gets F’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of PTIE stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
